S&P Capital IQ has a positive fundamental outlook for biotechnology over the next 12 months, based on accelerating revenue and earnings growth from several large-cap, profitable names in the group, suggests Steven Silver, S&P Capital IQ equity analyst in The Outlook.
In our view, Amgen (AMGN), Celgene (CELG), and Gilead Sciences (GILD) each has bolstered its long-term growth prospects in recent years.
Celgene, which had been reliant on its multiple myeloma drug Revlimid for the majority of its revenue, secured approval of internally-developed Pomalyst for late-stage multiple myeloma.
Its Apremilast is currently under Food and Drug Administration (FDA) review for the anti-inflammatory condition, psoriatic arthritis, and has also shown promise in such indications as psoriasis and ankylosing spondylitis.
In 2010, Celgene acquired rights to cancer drug Abraxane, which was approved in breast cancer at the time of the deal, but has subsequently been approved for lung and pancreatic cancer, the latter of which we view as a major advance in the treatment paradigm.
5 Best Stocks To Own Right Now: AFC Enterprises Inc.(AFCE)
AFC Enterprises, Inc. develops, operates, and franchises quick-service restaurants under the trade names of Popeyes Chicken & Biscuits and Popeyes Louisiana Kitchen. As of December 25, 2011, it operated and franchised 2,035 Popeyes restaurants in 45 states, the District of Columbia, Puerto Rico, Guam, the Cayman Islands, and 25 foreign countries. The company was founded in 1972 and is headquartered in Atlanta, Georgia.
Advisors' Opinion:- [By AnnaLisa Kraft]
AFC Enterprises (NASDAQ: AFCE ) , which owns the Popeye's Louisiana Kitchen quick- serve chain, once an undiscovered gem, has now soared 66% over the last year.
- [By Seth Jayson]
AFC Enterprises (Nasdaq: AFCE ) reported earnings on May 29. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended April 21 (Q1), AFC Enterprises beat expectations on revenues and met expectations on earnings per share.
5 Best Stocks To Own Right Now: Lafe Corporation Limited (L05.SI)
Lafe Corporation Limited, an investment holding company, primarily engages in property development, property investment, and property related service businesses. The company is involved in the development, investment, sale, and leasing of real estate properties. It also provides property appraisal, property management, architectural consultancy, building consultancy, corporate administration, real estate agency, security guard, and property consultancy services. In addition, the company holds trademarks It has operations in Singapore, Hong Kong, and the People�s Republic of China. The company was incorporated in 1999 and is based in Singapore. Lafe Corporation Limited is a subsidiary of Clarendon Investments Capital Limited.
Top 10 Tech Stocks To Invest In Right Now: Cardiome Pharma Corporation(CRME)
Cardiome Pharma Corp., a life sciences company, engages in developing proprietary drugs to treat or prevent cardiovascular and other diseases. The company offers BRINAVESS, a product approved for marketing in the European Union, Iceland, and Norway for the conversion of recent onset atrial fibrillation to sinus rhythm in adults. It also has clinical programs, which focuses on the treatment of atrial fibrillation, an arrhythmia (or abnormal rhythm) of the upper chambers of the heart. The company has a phase 1 program for GED-aPC, an engineered analog of recombinant human activated Protein C that completed phase I clinical trials for the treatment of infectious disease. In addition, Cardiome Pharma Corp. has pre-clinical projects that focus on cardiac diseases, ion channel conditions, and other indications. It also has a collaboration and license agreement with Merck & Co., Inc. (Merck), for the development and commercialization of vernakalant; and Astellas Pharma US, Inc. t o develop, make, and sell intravenous or injectable formulations of vernakalant in North America. The company was formerly known as Nortran Pharmaceuticals Inc. and changed its name to Cardiome Pharma Corp. in June 2001. Cardiome Pharma Corp. was founded in 1986 and is headquartered in Vancouver, Canada.
Advisors' Opinion:- [By Bryan Murphy]
Back on March 13th I penned some less-than-well-received thoughts on Cardiome Pharma Corp. (NASDAQ:CRME). Basically, I was warning that CRME was just one stumble away from a fairly significant selloff. Given that so many traders were a fan of the biotech stock at the time, merely posing the possibility of a dip was something of a threat to my life and limb.
- [By John Udovich]
The biotech sector along with small cap biotech stocks Cardiome Pharma Corp (NASDAQ: CRME), Oncolytics Biotech, Inc (NASDAQ: ONCY), Vital Therapies Inc (NASDAQ: VTL) and TNI BioTech (OTCMKTS: TNIB) have all been producing their share of news this week for investors and traders alike to trade on. Moreover and while some 42 ��ife sciences��companies have gone public raising about $3 billion from investors so far this year, there are a growing number of biotechs pulling the plug on upcoming IPOs who are citing market conditions. With that in mind, here is a look at important news from the biotech sector and small cap biotech stocks this week:
5 Best Stocks To Own Right Now: Western Refining Inc.(WNR)
Western Refining, Inc. operates as an independent crude oil refiner and marketer of refined products. The company operates in three segments Refining Group, Wholesale Group, and Retail Group. The Refining Group segment operates two refineries in Texas and Mexico; two stand-alone refined product distribution terminals in New Mexico; and four asphalt terminals in Texas, as well as operates crude oil transportation and gathering pipeline system in New Mexico. It refines various grades of gasoline, diesel fuel, jet fuel, and other products from crude oil, other feedstocks, and blending components; and acquires refined products through exchange agreements and from various third-party suppliers. This segment sells its products through its wholesale group and service stations, independent wholesalers and retailers, commercial accounts, and sales and exchanges with oil companies. The Wholesale Group segment distributes commercial wholesale petroleum products primarily in Arizona, California, Colorado, Nevada, New Mexico, Texas, and Utah for retail fuel distributors, as well as for the mining, construction, utility, manufacturing, transportation, aviation, and agricultural industries. The Retail Group segment operates service stations, which include convenience stores or kiosks that sell various grades of gasoline, diesel fuel, general merchandise, and beverage and food products to the general public. As of February 24, 2012, it operated 210 service stations with convenience stores or kiosks located in Arizona, New Mexico, Colorado, and Texas. The company was incorporated in 2005 and is headquartered in El Paso, Texas.
Advisors' Opinion:- [By Eric Volkman]
Western Refining (NYSE: WNR ) investors are about to find a few more coins in their pockets. The company has declared a Q3 dividend of $0.18 per share, to be paid on Aug. 15 to shareholders of record as of July 31. That amount is exactly 50% higher than Western Refining's previous disbursement of $0.12, which was handed out in early May.
- [By Aimee Duffy]
It;s been a very robust year for master limited partnership IPOs to say the least. On Thursday, Western Refining (NYSE: WNR ) successfully spun off its midstream logistics MLP, Western Refining Logistics (NYSE: WNRL ) . The partnership became the 14th MLP to make its debut this year.
- [By Roberto Pedone]
Another stock that's starting to trend within range of triggering a near-term breakout trade is Western Refining (WNR), a crude oil refiner and marketer of refined products. It also operates service stations and convenience stores. This stock is off to a decent start in 2013, with shares up 10.8%.
If you look at the chart for Western Refining, you'll notice that this stock has been uptrending strong for the last month and change, with shares soaring higher from its low of $25.47 to its recent high of $32.09 a share. During that uptrend, shares of WNR have been consistently making higher lows and higher highs, which is bullish technical price action. This stock has also moved back above both its 50-day and 200-day moving averages, which is bullish. That move has now pushed shares of WNR within range of triggering a near-term breakout trade.
Traders should now look for long-biased trades in WNR if it manages to break out above some near-term overhead resistance at $32.09 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.96 million shares. If that breakout triggers soon, then WNR will set up to re-test or possibly take out its next major overhead resistance levels at $34 to $36.50 a share. Any high-volume move above $36.50 will then give WNR a chance to tag its 52-week high at $39.42 a share.
Traders can look to buy WNR off any weakness to anticipate that breakout and simply use a stop that sits right below either its 200-day at $30.06 a share or its 50-day at $29.30 a share. One can also buy WNR off strength once it takes out that breakout level with volume and then simply use a stop that sits a comfortable percentage from your entry point.
This is yet again another name that the bears are in love with, since the current short interest as a percentage of the float for WNR is crazy high at 39.7%. A monster short-squeeze could easily tr
- [By Rich Smith]
On Tuesday, the Department of Defense awarded some $2.3 billion worth of contracts for "aviation turbine fuel." Most of the major oil and refining companies came away with contracts, including:
Royal Dutch Shell (NYSE: RDS-A ) subsidiary Equilon Enterprises, which claimed the largest award at an estimated $474.1 million in maximum value. Valero (NYSE: VLO ) , winner of a nearly as large contract valued at up to $456.4 million. ExxonMobil (NYSE: XOM ) , winner of a $405.1 million contract. Chevron (NYSE: CVX ) , which won $391.4 million. Western Refining (NYSE: WNR ) , awarded a $268.7 million supply contract.In addition, four other, smaller companies also won contracts. All nine contracts state June 30, 2014, as the deadline for delivery.
No comments:
Post a Comment